Skip to main content
Premium Trial:

Request an Annual Quote

Tempus Gets CE Mark for xT Tumor Sequencing Assay

NEW YORK – AI precision medicine firm Tempus said on Tuesday that it has obtained the CE mark for its cancer genomic sequencing assay, xT, making the test available for clinical use in Europe and other countries that accept the designation.

According to the company, the xT assay is already used by thousands of oncologists in the US, and broadening availability to European clinicians is part of the firm's regulatory strategy.

In addition to making the test available for patients in the region, the CE mark also allows Tempus and its partners to expand its adoption for local clinical trial enrollment.

Tempus Founder and CEO Eric Lefkofsky said in a statement that the xT test provides some of the most comprehensive molecular profiling in the market, with added insights derived from clinical context.

The company's xT platform integrates a patient’s structured clinical data with molecular data from DNA and RNA sequencing of solid tumors. Specifically, it detects somatic single nucleotide variants, insertions, and deletions from DNA sequencing across 648 genes, as well as gene fusions using RNA whole-transcriptome sequencing.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.